Lund, S.E., April 22, 2024 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces the release of its Sustainability Report 2023, showcasing significant strides in environmental stewardship, social responsibility, and sustainable business practices. This marks the fifth edition of the report, detailing TFS’s sustainability initiatives, achievements, and future aspirations.
Read the full report here.
“Our commitment to sustainability is not just a goal; it’s a fundamental principle that guides our actions and decisions,” remarks Patrik Darsund, Chief People Officer at TFS. “We are proud of the progress we’ve made and remain committed to advancing sustainability in everything we do.”
TFS’s Sustainability Report 2023 highlights significant advancements across various fronts:
Environmental (E):
- Enhanced Carbon Management: Adoption of advanced CO2 emission tracking tools demonstrates proactive environmental stewardship, aligning operations with regulatory standards and emphasizing transparency in environmental impact.
- Sustainable Operations Initiatives: Implementation of a global travel booking platform and investment in renewable energy sources and eco-friendly procurement practices minimize TFS’ environmental footprint and support climate action.
- Commitment to Science-Based Targets: Initiating the Science-Based Targets initiative (SBTi) reflects a strategic approach to reducing carbon emissions, aligning with global efforts to combat climate change.
Social (S):
- Diversity and Inclusion: A workforce composition reflecting a strong commitment to gender diversity at all levels of the organization fosters an inclusive workplace culture that values and respects diversity.
- Employee Engagement and Development: High engagement scores and extensive training initiatives illustrate TFS’s investment in employees’ professional growth and well-being, emphasizing the importance of people in achieving the company’s mission.
- Community Engagement and Impact: Strategic partnerships and community engagement initiatives demonstrates a commitment to broader social issues, including health disparities and access to clinical trials, driving positive societal change.
Governance (G):
- Ethical Conduct and Compliance: Reinforced ethical business practices through policies and training programs and a zero-tolerance stance towards corruption, underscores TFS’s commitment to integrity, transparency, and accountability in all its operations.
- Strategic Leadership and Oversight: The Executive Committee’s active involvement in sustainability commitments and adoption of global ESG reporting standards demonstrate effective steering towards sustainability goals.
- Risk Management and Data Protection: Holistic risk management, including data privacy and security, showcases a commitment to safeguarding stakeholders’ interests and ensuring service integrity and reliability.
This report underscores the company’s dedication to sustainability and exemplifies the progress made, reinforcing TFS’ position as a frontrunner in the pursuit of environmentally conscious and socially responsible business practices.
Dr. Bassem Saleh, Chief Executive Officer at TFS, further emphasizes, “Our achievements in earning the EcoVadis Silver rating for the fourth consecutive year and improving our Carbon Disclosure Project score underscore our unwavering dedication to environmental stewardship and transparency. Moreover, our commitment to the Science-based Targets Initiative reflects our proactive stance in addressing climate change through concrete, science-driven strategies. These milestones not only validate our efforts but also inspire us to continuously raise the bar in sustainability excellence.”
For more information on TFS HealthScience’s Sustainability Report 2023 and its commitment to sustainability, please visit the CRO’s site here.
About TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. In partnership with customers, we build solution-driven teams working towards a healthier future. Bringing together nearly 800+ professionals, TFS delivers tailored clinical research services in more than 40 countries with flexible clinical development and strategic resourcing solutions across key therapeutic areas, including Dermatology, Immunology & Inflammatory Diseases, Internal Medicine, Neuroscience, Oncology & Hematology, and Ophthalmology.
Detailed information about TFS and its business offerings can be obtained through www.tfscro.com